FindTrial
Sign In

The Effect of Rocuronium Infusion after Neurophysiological Monitoring on the Time to Emergence and the Time to Tracheal Extubation during Surgeries in Cerebellopontine Angle Area Maintained without Muscle Relaxant

Neurophysiological Monitoring on the Time to Emergence and the Time to Tracheal Extubation during Surgeries in Cerebellopontine Angle Area Maintained without Muscle Relaxant

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100043693
Enrollment
Unknown
Registered
2021-02-27
Start date
2021-03-01
Completion date
Unknown
Last updated
2021-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hemifacial spasm and tumor in cerebellopontine angle

Interventions

experimental group:Rocuronium
control group:Nil

Sponsors

Zhongshan Hospital, Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Patients undergoing surgeries in cerebellopontine angle area, aged 18-70 years; (2) ASA I-II; (3) BMI 18.5-28 kg/m2; (4) Normal preoperative heart, lung, liver kidney function and normal complete blood count; (5) Sign informed consent.

Exclusion criteria

Exclusion criteria: (1) With diseases in neuromuscular junction or myasthenia gravis; (2) with depression, anxiety, schizophrenia or other mental disorders; (3) with severe hypertension, diabetes, coronary disease,heart valve diseases or cerebral infarction.

Design outcomes

Primary

MeasureTime frame
Time to Tracheal Extubation;—

Secondary

MeasureTime frame
Time to Emergence;Heart Rate;Blood Pressure;bispectral index, BIS;the amount of remifentanil;the amount of sufentanil;the amount of propofol;anesthesia cost;—

Countries

China

Contacts

Public ContactGe Shengjin

Zhongshan Hospital, Fudan University

ge.shengjin@zs-hospital.sh.cn+86 13601926171

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026